Millennium Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,733
| Closed | -$32.1K | – | 6708 |
|
|
2024
Q1 | $32.1K | Sell |
3,733
-5,840
| -61% | -$27.9K | ﹤0.01% | 5759 |
|
|
2023
Q4 | $33.5K | Buy |
+9,573
| New | +$33.7K | ﹤0.01% | 5546 |
|
|
2023
Q3 | – | Sell |
-1,058
| Closed | -$6.16K | – | 6704 |
|
|
2023
Q2 | $6.16K | Buy |
1,058
+470
| +80% | +$8.59K | ﹤0.01% | 5833 |
|
|
2023
Q1 | $22K | Buy |
+588
| New | +$19.3K | ﹤0.01% | 5845 |
|
|
2022
Q4 | – | Sell |
-1,720
| Closed | -$57K | – | 7213 |
|
|
2022
Q3 | $57K | Sell |
1,720
-2,041
| -54% | -$77.9K | ﹤0.01% | 6142 |
|
|
2022
Q2 | $150K | Buy |
+3,761
| New | +$146K | ﹤0.01% | 5770 |
|
|
2021
Q4 | – | Sell |
-6,974
| Closed | -$540K | – | 7526 |
|
|
2021
Q3 | $540K | Buy |
+6,974
| New | +$590K | ﹤0.01% | 5277 |
|
|
2021
Q2 | – | Sell |
-2,590
| Closed | -$426K | – | 7265 |
|
|
2021
Q1 | $426K | Sell |
2,590
-4,865
| -65% | -$937K | ﹤0.01% | 4953 |
|
|
2020
Q4 | $1.74M | Buy |
7,455
+3,997
| +116% | +$556K | ﹤0.01% | 3343 |
|
|
2020
Q3 | $358 | Sell |
3,458
-131
| -4% | -$7.01K | ﹤0.01% | 3748 |
|
|
2020
Q2 | $141K | Buy |
3,589
+2,143
| +148% | +$84.8K | ﹤0.01% | 3928 |
|
|
2020
Q1 | $48K | Buy |
+1,446
| New | +$84K | ﹤0.01% | 3671 |
|
|
2018
Q4 | – | Sell |
-372
| Closed | -$152K | – | 4279 |
|
|
2018
Q3 | $152K | Sell |
372
-120
| -24% | -$55.6K | ﹤0.01% | 3686 |
|
|
2018
Q2 | $266K | Buy |
492
+309
| +169% | +$164K | ﹤0.01% | 3446 |
|
|
2018
Q1 | $84K | Buy |
183
+52
| +40% | +$28.4K | ﹤0.01% | 3493 |
|
|
2017
Q4 | $88K | Buy |
131
+72
| +122% | +$43.5K | ﹤0.01% | 3678 |
|
|
2017
Q3 | $37K | Buy |
+59
| New | +$30.7K | ﹤0.01% | 3426 |
|
|
2015
Q2 | – | Sell |
-132
| Closed | -$372K | – | 3956 |
|
|
2015
Q1 | $372K | Buy |
+132
| New | +$347K | ﹤0.01% | 2916 |
|
Other funds holding TCON
Millennium Management's TCON Position: Q2 2024 in Review
Millennium Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q2 2024, closing a stake of 3,733 shares — an estimated $32.1K sold.
Millennium Management first reported a position in TCON in Q1 2015 and held it in 18 quarters. The position peaked at $1.74M in Q4 2020. 1 fund tracked by Wall St. Rank holds TCON as of Q2 2024.
- Millennium Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Millennium Management sold 3,733 TRACON Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $32.1K.
- Millennium Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2015 and held it in 18 quarters.
- Millennium Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $1.74M in Q4 2020.
- 1 fund tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Millennium Management's 13F filing for Q2 2024, filed 14 Aug 2024.